Overall Assessment: The stock has exhibited an exceptionally strong uptrend over the past six months, with a gain of 64.77%, significantly outperforming the broader market which declined 2.82% over the same period. This momentum is highlighted by a dramatic surge from around $90 in late January 2026 to a peak above $160 in late February.

Short-term Performance: Over the last three months, the stock has surged 55.29%, dramatically outpacing the S&P 500's decline of 4.63%. However, the stock has pulled back from its highs, declining 9.58% over the past month, which still represents a relative underperformance compared to the S&P 500's 5.25% decline.

Current Position: The current price of $135.97 sits well within the 52-week range of $37.31 to $162.10, representing approximately 83% of the range's high. The recent pullback from the February peak suggests a consolidation phase after the explosive rally.

Revenue & Profitability: The company's most recent quarterly revenue (Q4 2025) was $4.22 billion, representing a 20.4% year-over-year growth. Profitability has improved significantly, with the net margin expanding to 12.8% in Q4 2025, up from 8.9% in the year-ago quarter, driven by a gross margin of 35.3% and operating margin of 16.6%.

Financial Health: The company maintains a solid current ratio of 1.59, indicating good short-term liquidity. The debt-to-equity ratio stands at 0.87, reflecting a moderate level of leverage. Free cash flow generation is strong, with trailing twelve-month free cash flow of $1.41 billion.

Operational Efficiency: Return on Equity (ROE) is a healthy 13.5%, and Return on Assets (ROA) is 4.95%. The company's asset turnover and operational efficiency have shown improvement alongside the revenue growth and margin expansion.